Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.41 |
| ▸ | TRPM8 | Q7Z2W7 | 3/20 | 0.40 |
| ▸ | DHODH | Q02127 | 2/20 | 0.40 |
| ▸ | MMP2 | P08253 | 1/20 | 0.39 |
| ▸ | MMP13 | P45452 | 1/20 | 0.39 |
| ▸ | PRMT5 | O14744 | 2/20 | 0.38 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.38 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.37 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.37 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.37 |
| ▸ | PPARD | Q03181 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13109711 | 0.99 | CYP1A2 (0.41) | CYP1A2CYP2C19KDM4EHPGDSMN1; SMN2 | |
| SCHEMBL3453185 | 0.92 | TRPM8 (0.41) | CYP1A2CYP2C19KDM4EHPGDSMN1; SMN2 | |
| SCHEMBL3452204 | 0.89 | MRGPRX4 (0.45) | CYP1A2CYP2C19KDM4EHPGDSMN1; SMN2 | |
| SCHEMBL3452584 | 0.88 | ALOX5 (0.47) | CYP1A2CYP2C19KDM4EHPGDSMN1; SMN2 | |
| SCHEMBL13109714 | 0.88 | MRGPRX4 (0.45) | CYP1A2CYP2C19KDM4EHPGDSMN1; SMN2 | |
| SCHEMBL13109717 | 0.87 | ALOX5 (0.48) | CYP1A2CYP2C19KDM4EHPGDSMN1; SMN2 | |
| SCHEMBL13109703 | 0.83 | CYP1A2 (0.40) | CYP1A2CYP2C19KDM4EHPGDSMN1; SMN2 | |
| SCHEMBL3452582 | 0.83 | MMP13 (0.41) | CYP1A2CYP2C19KDM4EHPGDSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL3453451 | 0.83 | CYP1A2 (0.39) | CYP1A2CYP2C19KDM4EHPGDSMN1; SMN2 | |
| SCHEMBL3452202 | 0.82 | KDM4E (0.40) | CYP1A2CYP2C19KDM4EHPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7820704-B2 | Substituted heteroaryl derivatives, compositions, and methods of use | TRANSTECH PHARMA, INC. (US) | 2010-10-26 | — | — | US | disclosed |
| US-20050261294-A1 | Substituted heteroaryl derivatives, compositions, and methods of use | VTVX HOLDINGS I LLC | 2005-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050261294-A1 | Substituted heteroaryl derivatives, compositions, and methods of use | MC5R, MC3R, MC4R | CYP1A2 261/4885CYP2C19 286/4885KDM4E 2378/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.